FTC Acts to Stop Two Companies from Making Unproven Bone and Joint Claims
The FTC filed a complaint against ZyCal Bioceuticals, that has marketed a line of joint pain relief products under the brand name Ostinol.
- The FTC filed a complaint against ZyCal Bioceuticals, that has marketed a line of joint pain relief products under the brand name Ostinol.
- According to the FTC, the pills sold by both companies use the same active ingredient, Cyplexinol, and both companies claimed that their pills grow bone and cartilage, thereby providing relief from joint pain.
- The FTC contends that the claims made by both companies are false and not supported by scientific evidence.
- Under a proposed court order, they are prohibited from making health-related product claims unless such claims are supported by competent and reliable scientific evidence.